Particle.news
Drug Development Pharmaceuticals Corporate Finance Earnings Reports Market Trends Stock Market Corporate Earnings Drug Sales Investment Strategies Market Analysis
The pharmaceutical giant's diabetes and obesity drugs fueled a 45% revenue surge, but profit guidance was cut due to acquisition costs and CVS's formulary change.
